Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
COMMENTARY / World
Jul 26, 2020
Britain's response to COVID-19 has been world class
One country has done more than any other to stop the spread of the coronavirus.
Japan Times
WORLD / Science & Health
Jul 21, 2020
Wave of promising study results raise hopes for coronavirus vaccines
Early data from trials of three potential COVID-19 vaccines released on Monday, including a closely watched candidate from Oxford University, increased confidence that a vaccine can train the immune system to recognize and fight the novel coronavirus without serious side effects.
Japan Times
BUSINESS / Companies
Jul 17, 2020
Japan in talks with Johnson & Johnson to secure COVID-19 vaccine
The company has already agreed to prioritize an allocation to the United States as part of a funding agreement, according to the firm's chief financial officer.
Japan Times
WORLD / FOCUS
Jul 17, 2020
Coronavirus cold war flares up with claims of Russian vaccine hack
The international race for protection from the virus escalated to a new level with allegations that vaccine development has become a target of Russian cyberattacks.
Japan Times
BUSINESS / Companies
Jul 14, 2020
Pfizer and BioNTech coronavirus vaccine candidates on FDA fast track
The U.S.-listed shares of the German firm climbed about 15 percent, while Pfizer's stock rose about 5 percent.
JAPAN / Science & Health
Jul 10, 2020
Avigan's effectiveness inconclusive in Japan COVID-19 trial
Promoted heavily by Prime Minister Shinzo Abe, the flu drug did not yield any statistically significant results after administered to 89 patients across Japan.
Japan Times
COMMENTARY / World
Jul 8, 2020
The fight over a coronavirus vaccine will get ugly
Once COVID-19 shots become available, there will be arguments about who gets them, and an even bigger battle with anti-vaxxers who refuse them.
Japan Times
WORLD / Science & Health
Jul 7, 2020
Moderna spars with U.S. scientists over COVID-19 vaccine trials
As the United States accelerates the search for a coronavirus vaccine, tensions have erupted between government scientists and Moderna Inc., one of the leading developers, it has been learned.
Japan Times
BUSINESS
Jul 3, 2020
How Moderna execs are cashing in during the race to develop COVID-19 vaccine
Biotech firm Moderna Inc. could reap tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If it loses, the early-stage company’s value could crash.
Japan Times
ASIA PACIFIC / Science & Health
Jul 2, 2020
How China's CanSino Biologics jumped to the front of the coronavirus vaccine race
The firm has boosted its scientific prowess by tying up with the Canadian government's largest research organization, maintaining links despite geopolitical rows.
JAPAN / Science & Health
Jun 24, 2020
Wanted: More COVID-19 patients in Japan ... for clinical trials
Japan has become a victim of its own success as slowing new infections have led to a shortage of patients to enroll in trials for treatments and vaccines.
Japan Times
BUSINESS / Companies
Jun 23, 2020
Gilead targets remdesivir supply for 2 million COVID-19 patients by year-end
The company also said it hoped to start trials in August of an easier-to-use inhaled version of the medicine, which is currently administered only intravenously.
BUSINESS / Companies
Jun 22, 2020
Japan drugmaker to tie up with universities to develop new test method for coronavirus
Japanese pharmaceutical company Shionogi & Co. said Monday that it will collaborate with universities in the country to put into practical use a new testing method for the novel coronavirus.
Japan Times
BUSINESS / Markets
Jun 8, 2020
Chugai stock surges 60% to rival Sony's value on hopes for virus treatment
Chugai Pharmaceutical is now Japan's biggest drug company by market value after overtaking Daiichi Sankyo and Takeda Pharmaceutical.
Japan Times
WORLD / Science & Health
Jun 2, 2020
Scientists hunt pandemic hot spots in race to test vaccines
The first wave of the COVID-19 pandemic may be waning. For vaccine developers, that could be a problem.
Japan Times
WORLD / Science & Health
Jun 1, 2020
After fast-tracking Japanese COVID-19 drug, Russia to roll out 'game changer' next week
Russia will start administering its first approved antiviral drug to treat coronavirus patients next week, its state financial backer told Reuters, a move it described as "a game changer" that should speed a return to normal economic life.
Japan Times
BUSINESS / Markets
May 26, 2020
Japan’s AnGes continues surge as coronavirus vaccine candidate moves closer to human trials
The progress of its drug development has led to wild swings in the stock, with shares falling more than 50 percent in two trading sessions earlier this month.
Japan Times
WORLD / Science & Health
May 23, 2020
Gilead’s remdesivir mainly helped healthier COVID-19 patients
Gilead Sciences Inc.’s remdesivir, the first medicine cleared for the treatment of COVID-19, mainly benefited healthier patients who weren’t dependent on ventilators or heart-lung bypass machines, according to published results of the study used to get the medicine on the market.
Japan Times
BUSINESS
May 21, 2020
No pause in coronavirus trial for Avigan, Japan's lead researcher says
The lead researcher in the coronavirus trial for flu drug Avigan says it’s too early to make a call on whether it works and shrugged off negative reports about the interim results, saying patients are still being enrolled.
Japan Times
COMMENTARY / World
May 19, 2020
Vaccine developers need to take their time
Positive study results have arrived quickly, but the next steps will be slower.

Longform

Mount Fuji is considered one of Japan's most iconic symbols and is a major draw for tourists. It's still a mountain, though, and potential hikers need to properly prepare for any climb.
What it takes to save lives on Mount Fuji